Lead sponsor
University of Virginia
9 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
9
Trials led
4
Active
547
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
2
Phase 3
1
Phase 4
3
Not applicable
3
Trials by status
Not yet recruiting
1
Recruiting
3
Completed
1
Terminated
2
Suspended
1
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection FractionEF ≥50%Ph 4Recruiting192
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy—Ph 2Recruiting120
Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes MellitusHbA1c ≥6.5%not applicableCompleted9